Collateral circulation after revascularization in moyamoya disease: influencing factors and underlying mechanisms
By
Zhenwei Li
Liming Zhao
Pengpeng Yan
Shangyu Jin
Hao Liang
Ziqiang Liu
Yang Liu
Yuxue Sun
Tao Gao
Chaoyue Li
Gaochao Guo
July 6, 2026
Clinical Scorecard: Factors Influencing Collateral Circulation Development Following Revascularization in Moyamoya Disease: Mechanisms and Implications
At a Glance
Category Detail
Condition Moyamoya Disease
Key Mechanisms Genetic susceptibility, angiogenic growth factors, cellular components, structural regulators, clinical variables
Target Population Patients with moyamoya disease undergoing cerebral revascularization
Care Setting Cerebral revascularization surgery
Key Highlights
Cerebral revascularization improves cerebral perfusion and may reduce stroke recurrence. Postoperative collateral circulation formation varies significantly among individuals. Factors influencing collateral circulation include genetic variants, angiogenic factors, and surgical modalities. Direct revascularization may lead to better angiographic outcomes and lower stroke risk compared to indirect methods. Poor collateral circulation is associated with higher incidence of recurrent ischemia and hemorrhage.
Guideline-Based Recommendations
Diagnosis
Diagnosis of moyamoya disease is based on clinical presentation and angiographic findings.
Management
Cerebral revascularization is the primary treatment for moyamoya disease.
Monitoring & Follow-up
Monitor for recurrent ischemia or hemorrhage post-revascularization.
Risks
Risks include hyperperfusion syndrome and variability in collateral circulation formation.
Patient & Prescribing Data
Patients with moyamoya disease undergoing surgical intervention.
Pharmacological treatments have limited effects; surgical options are preferred.
Clinical Best Practices
Consider genetic testing for RNF213 variants in patients with moyamoya disease. Evaluate surgical modality based on individual patient risk factors and expected outcomes. Implement a multidisciplinary approach for managing moyamoya disease.
Related Resources & Content